摘要
Boron neutron capture therapy (BNCT) is a promising therapy for malignant tumors that requires selective and high concentrations of B-10 accumulation in tumor cells. Despite ongoing developments in novel boron agents and delivery carriers, the progress and clinical application of BNCT is still restricted by the low B-10 accumulation and tumor-to-normal tissue (T/N) ratio. Herein, a dissolving microneedle-based transdermal drug delivery system was specifically designed for BNCT in a mouse model of melanoma. By incorporating fructose-BPA (F-BPA) into PVA microneedle tips, this system successfully delivered sufficient F-BPA into the melanoma site after the application of only two patches. Notably, the T/N ratio achieved through the treatment combining PVA/F-BPA MNs with BNCT (PVA/F-BPA MNs-BNCT) surpassed 93.16, signifying a great improvement. Furthermore, this treatment approach effectively inhibited tumor growth and significantly enhanced the survival rate of the mice. In brief, our study introduces a novel, simple, and efficient administration strategy for BNCT, opening new possibilities for the design of nanomedicine for BNCT.
学科与关键词
- Engineered microneedle systems for topical cancer therapyJiang, Xingyu; Xia, Wenzheng; Pan, Jiaxing; Yang, Wenfang; Zhang, Shunan; Li, Chunming; Zan, Tao; Lai, Yi*; Xu, Zhiai; Yu, Haijun*Applied Materials Today, 2023, 31: 101774.被引 4
- Boron-peptide conjugates with angiopep-2 for boron neutron capture therapyXiang, Jing; Ma, Lin; Tong, Jianfei; Zuo, Nan; Hu, Weitao; Luo, Yupeng; Liu, Junqi; Liang, Tianjiao; Ren, Qiushi*; Liu, Qi*Frontiers in Medicine, 2023, 10: 1199881.
- pH-activatable oxidative stress amplifying dissolving microneedles for combined chemo- photodynamic therapy of melanomaHuang, Yanjuan; Lai, Hualu; Jiang, Jingwen; Xu, Xiaoyu; Zeng, Zishan; Ren, Lingling; Liu, Qiuxing; Chen, Meixu; Zhang, Tao; Ding, Xin; Zhao, Chunshun; Cui, Shengmiao*Asian Journal of Pharmaceutical Sciences, 2022, 17(5): 679-696.被引 15
